The mortality rate from bladder malignant neoplasms in Brazil is projected to increase steadily from 2024 to 2028, starting at 8.1 and reaching 8.9 deaths per hundred thousand men by 2028. Compared to 2023 levels, this indicates a steady upward trend.
The yearly increase from 2024 to 2025 is approximately 2.47%, followed by a similar rate of 2.41% and 2.35% in subsequent years. The compound annual growth rate (CAGR) for this period is around 2.41%, reflecting a consistent rise in mortality rates.
Future trends to watch for include potential advancements in bladder cancer treatment and early detection protocols which might slow this upward trend. Additionally, changes in healthcare policies or successful public health campaigns could influence these projections by improving patient outcomes and survival rates.
Other factors, such as demographic shifts and lifestyle changes in Brazil, could also impact these future mortality rates.
